Dysregulation of lncRNAs GM5524 and GM15645 involved in high‑glucose‑induced podocyte apoptosis and autophagy in diabetic nephropathy

Feng,Yamin; Chen,Sheng; Xu,Jiarong; Zhu,Qun; Ye,Xiaolong; Ding,Dafa; Yao,Weihao; Lu,Yibing

doi:10.3892/mmr.2018.9412

Dysregulation of lncRNAs GM5524 and GM15645 involved in high‑glucose‑induced podocyte apoptosis and autophagy in diabetic nephropathy

Authors:
- Yamin Feng
- Sheng Chen
- Jiarong Xu
- Qun Zhu
- Xiaolong Ye
- Dafa Ding
- Weihao Yao
- Yibing Lu
View Affiliations

Affiliations: Department of Endocrinology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China, Department of Endocrinology, Baoying People's Hospital, Yangzhou, Jiangsu 225800, P.R. China
Published online on: August 21, 2018 https://doi.org/10.3892/mmr.2018.9412
Pages: 3657-3664
Copyright: © Feng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic nephropathy (DN) is an important microvascular complication of diabetes, and one of the leading causes of end‑stage kidney disease. However, the mechanism of the DN pathogenic process remains unclear. Recently, long non‑coding (lnc)RNA dysregulation has been regarded to cause the occurrence and development of various human diseases, although the functions of lncRNAs in human DN are poorly understood. The authors' previous study using microarray analysis identified hundreds of dysregulated lncRNAs in DN, although the functions of these lncRNAs were not demonstrated. Out of those dysregulated lncRNAs, Gm5524 was significantly upregulated in response to DN, while Gm15645 was significantly downregulated in response to DN. In the present study, this result was further validated by reverse transcription‑quantitative polymerase chain reaction assays, and downregulating or overexpressing Gm5524 and Gm15645 in mouse podocytes. Notably, knockdown of Gm5524 and overexpression of Gm15645 induced mouse podocyte apoptosis and decreased cell autophagy in high‑glucose culture conditions. In conclusion, the results of the present study revealed the roles of lncRNAs Gm5524 and Gm15645 in high‑glucose induced podocyte apoptosis and autophagy during DN, which may further the understanding of the involvement of lncRNAs in DN, and provide a potential novel therapeutic target for this disease.

View Figures

View References

1	Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA and Lernmark Å: Type 1 diabetes mellitus. Nat Rev Dis Primers. 3:170162017. View Article : Google Scholar : PubMed/NCBI
2	Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R and Bhansali A: Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 5:714–721. 2014. View Article : Google Scholar : PubMed/NCBI
3	Adeshara KA, Diwan AG and Tupe RS: Diabetes and complications: Cellular signaling pathways, current understanding and targeted therapies. Curr Drug Targets. 17:1309–1328. 2016. View Article : Google Scholar : PubMed/NCBI
4	Gregg EW, Sattar N and Ali MK: The changing face of diabetes complications. Lancet Diabetes Endocrinol. 4:537–547. 2016. View Article : Google Scholar : PubMed/NCBI
5	Magee C, Grieve DJ, Watson CJ and Brazil DP: Diabetic Nephropathy: A tangled web to unweave. Cardiovasc Drugs Ther. 31:579–592. 2017. View Article : Google Scholar : PubMed/NCBI
6	Han Q, Zhu H, Chen X and Liu Z: Non-genetic mechanisms of diabetic nephropathy. Front Med. 11:319–332. 2017. View Article : Google Scholar : PubMed/NCBI
7	Sharma D, Bhattacharya P, Kalia K and Tiwari V: Diabetic nephropathy: New insights into established therapeutic paradigms and novel molecular targets. Diabetes Res Clin Pract. 128:91–108. 2017. View Article : Google Scholar : PubMed/NCBI
8	Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al: Landscape of transcription in human cells. Nature. 489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
9	Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S, et al: GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res. 22:1760–1774. 2012. View Article : Google Scholar : PubMed/NCBI
10	Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, et al: The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
11	Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell. 136:629–641. 2009. View Article : Google Scholar : PubMed/NCBI
12	Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: Insights into functions. Nat Rev Genet. 10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
13	Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al: LincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
14	Fatica A and Bozzoni I: Long non-coding RNAs: New players in cell differentiation and development. Nat Rev Genet. 15:7–21. 2014. View Article : Google Scholar : PubMed/NCBI
15	He X, Ou C, Xiao Y, Han Q, Li H and Zhou S: LncRNAs: Key players and novel insights into diabetes mellitus. Oncotarget. 8:71325–71341. 2017.PubMed/NCBI
16	Shi X, Sun M, Liu H, Yao Y and Song Y: Long non-coding RNAs: A new frontier in the study of human diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
17	Bhan A and Mandal SS: Long noncoding RNAs: Emerging stars in gene regulation, epigenetics and human disease. ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
18	Wu B, Zhang C, Zou L, Ma Y, Huang K, Lv Q, Zhang X, Wang S, Xue Y, Yi Z, et al: LncRNA uc.48+ siRNA improved diabetic sympathetic neuropathy in type 2 diabetic rats mediated by P2×7 receptor in SCG. Auton Neurosci. 197:14–18. 2016. View Article : Google Scholar : PubMed/NCBI
19	Allison SJ: Diabetic nephropathy: A lncRNA and miRNA megacluster in diabetic nephropathy. Nat Rev Nephrol. 12:7132016. View Article : Google Scholar : PubMed/NCBI
20	Duan LJ, Ding M, Hou LJ, Cui YT, Li CJ and Yu DM: Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy. Biochem Biophys Res Commun. 484:598–604. 2017. View Article : Google Scholar : PubMed/NCBI
21	Wang M, Wang S, Yao D, Yan Q and Lu W: A novel long non-coding RNA CYP4B1-PS1-001 regulates proliferation and fibrosis in diabetic nephropathy. Mol Cell Endocrinol. 426:136–145. 2016. View Article : Google Scholar : PubMed/NCBI
22	Hu M, Wang R, Li X, Fan M, Lin J, Zhen J, Chen L and Lv Z: LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin. J Cell Mol Med. 21:2732–2747. 2017. View Article : Google Scholar : PubMed/NCBI
23	Chen S, Dong C, Qian X, Huang S, Feng Y, Ye X, Miao H, You Q, Lu Y and Ding D: Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy. J Diabetes Complications. 31:569–576. 2017. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science. 329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
26	Wang KC and Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
27	Zhang J, Zhu Y and Wang R: Long noncoding RNAs in respiratory diseases. Histol Histopathol. 119662018.
28	Sallam T, Sandhu J and Tontonoz P: Long noncoding RNA discovery in cardiovascular disease: Decoding form to function. Circ Res. 122:155–166. 2018. View Article : Google Scholar : PubMed/NCBI
29	Saha P, Vermas S, Pathak RU and Mishra RK: Long noncoding RNAs in mammalian development and diseases. Adv Exp Med Biol. 1008:155–198. 2017. View Article : Google Scholar : PubMed/NCBI
30	Leung A and Natarajan R: Long noncoding RNAs in diabetes and diabetic complications. Antioxid Redox Signal. Oct 30–2017.(Epub ahead of print).
31	Sun Y and Liu YX: LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway. Eur Rev Med Phamacol Sci. 22:2941–2948. 2018.
32	Zhang N, Geng T, Wang Z, Zhang R, Cao T, Camporez JP, Cai SY, Liu Y, Dandolo L, Shulman GI, et al: Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia. JCI Insight. 3(pii): 1203042018. View Article : Google Scholar : PubMed/NCBI
33	Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li YJ, Tao ZF, Song YC, Chen Q and Jiang Q: lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 116:1143–1156. 2015. View Article : Google Scholar : PubMed/NCBI
34	Alvarez ML and DiStefano JK: Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS One. 6:e186712011. View Article : Google Scholar : PubMed/NCBI
35	Hamzawy M, Gouda SAA, Rashid L, Attia Morcos M, Shoukry H and Sharawy N: The cellular selection between apoptosis and autophagy: Roles of vitamin D, glucose and immune response in diabetic nephropathy. Endocrine. 58:66–80. 2017. View Article : Google Scholar : PubMed/NCBI